Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 17 February 2021. Geoff Martha.

Executive Summary

According to a new report by Meddevicetracker, the global insulin pump market is expected to reach $5.1bn in 2024, a CAGR of 10.4%. Several insulin pump makers are expected to launch new products this year. See what Medtronic’s CEO, Geoff Martha, said about it here.

“The 780G in particular, has had a tremendous customer response in Europe, which bodes well for when we bring the technology to the US market.” – Geoff Martha, CEO, Medtronic

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts